Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Inventory (2023 - 2025)

Historic Inventory for Krystal Biotech (KRYS) over the last 3 years, with Q4 2025 value amounting to $40.5 million.

  • Krystal Biotech's Inventory rose 5268.98% to $40.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $40.5 million, marking a year-over-year increase of 5268.98%. This contributed to the annual value of $40.5 million for FY2025, which is 5268.98% up from last year.
  • According to the latest figures from Q4 2025, Krystal Biotech's Inventory is $40.5 million, which was up 5268.98% from $37.6 million recorded in Q3 2025.
  • Over the past 5 years, Krystal Biotech's Inventory peaked at $40.5 million during Q4 2025, and registered a low of $5.3 million during Q3 2023.
  • For the 3-year period, Krystal Biotech's Inventory averaged around $22.0 million, with its median value being $22.5 million (2024).
  • As far as peak fluctuations go, Krystal Biotech's Inventory surged by 27949.89% in 2024, and later surged by 5268.98% in 2025.
  • Krystal Biotech's Inventory (Quarter) stood at $7.0 million in 2023, then surged by 279.5% to $26.5 million in 2024, then surged by 52.69% to $40.5 million in 2025.
  • Its last three reported values are $40.5 million in Q4 2025, $37.6 million for Q3 2025, and $31.0 million during Q2 2025.